Daniel V. Correia

Daniel V. Correia

Universidade de Lisboa - Lisboa / Portugal
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4368995
University of Lisbon
person_outline Daniel V. Correia's MOST POPULAR ARTICLES
1-) Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cellsDV Correia, M Fogli, K Hudspeth, MG Da Silva, D Mavilio, B Silva-SantosBlood, The Journal of the American Society of Hematology 118 (4), 992-1001, 20111942011
2-) The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicityT Lanca, DV Correia, CF Moita, H Raquel, A Neves-Costa, C Ferreira, ...Blood, The Journal of the American Society of Hematology 115 (12), 2407-2411, 20101712010
3-) Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion/differentiation and preclinical proof of conceptAR Almeida, DV Correia, A Fernandes-Platzgummer, CL da Silva, ...Clinical Cancer Research 22 (23), 5795-5804, 20161402016
4-) Human γδ thymocytes are functionally immature and differentiate into cytotoxic type 1 effector T cells upon IL-2/IL-15 signalingJC Ribot, ST Ribeiro, DV Correia, AE Sousa, B Silva-SantosThe Journal of Immunology 192 (5), 2237-2243, 20141362014
5-) Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptorsDV Correia, AC Lopes, B Silva-SantosOncoimmunology 2 (1), e22892, 20131172013